baber/WOPTO huggingface dataset:
Patent JP-3967378-B2 (JP)
IPC: C08G18/67
Filed: 1996-03-22
Granted: 2007-08-29
Abstract: A macromonomer of the formula (I): Q-PFPE-L-M-L-PFPE-Q is described, wherein Q may be the same or different and is a polymerizable group, PFPE may be the same or different and is a perfluorinated polyether of formula (II): -CH2CF2O(CF2CF2O)x(CF2O)yCF2CH2O-, wherein the CF2CF2O and CF2O units may be randomly distributed or distributed as blocks throughout the chain and wherein x and y may be the same or different such that the molecular weight of the PFPE is in the range of from 242 to 4,000, L may be the same or different and is a difunctional linking group; and M is a residue from a difunctional polymer or copolymer wherein M has a molecular weight of 180 to 6000 comprising silicone repeat units of formula (III), where R<1> and R<2> may be the same or different and are selected from the group consisting of hydrogen, alkyl, aryl, halosubstituted alkyl, and the like. The macromonomer may be used in the production of contact lenses, corneal implants, cell growth substrates or medical implants.
Patent JP-4804598-B2 (JP)
IPC: C07K14/50
Filed: 1996-05-29
Granted: 2011-11-02
Abstract: The present invention provides therapeutic compositions for the prevention and treatment of pathological conditions involving bone and dental tissue. The present invention also provides a method to promote bone repair and/or growth for the treatment of pathological conditions involving bone tissue, for example, osteoporosis, Paget's disease, osteopetrosis, and periodontal disease and fracture repair, and healing of bone defects by administering FGF-1 to an animal or human in need of such treatment.
Patent MD-4007-B2 (MD)
Inventor: SCHILIOV VLADIMIR
IPC: G06K1/12
Filed: 2007-12-26
Abstract: Inventia se refera la domeniul tehnologiilor informationale si poate fi utilizata pentru aplicarea marcajelor de identificare pe resursele materiale solide, atat metalice, cat si dielectrice. Procedeul de aplicare a marcajului de identificare pe resursele materiale solide include imprimarea pe acestea a unui numar de identificare, aplicarea pe el a unei grile informationale si suflarea suprafetei acesteia cu un jet de gaze cu un amestec de particule metalice, care se formeaza intr-un invelis cu o duza ultrasonica, in care sunt instalate pe suporturi dielectrice elemente electroconductoare ce se volatilizeaza eruptiv la impulsionare electrica. In calitate de elemente electroconductoare se utilizeaza sarma sau staniol.
Patent ES-2358403-B2 (ES)
Title: Sistema para la administración de sustancias biológicamente activas que comprende poli-epsilón-caprolactona, poloxamina y una o varias sustancias activas.
Inventor: ALVAREZ LORENZO CARMEN
IPC: A61K9/22
Filed: 2009-10-26
Granted: 2011-12-13
Abstract: Sistema para la administración de sustancias
biológicamente activas que comprende
poli-\varepsilon-caprolactona,
poloxamina y una o varias sustancias activas. 
     La presente invención se refiere a un sistema
para la administración de sustancias biológicamente activas
que  comprende
poli-\varepsilon-caprolactona,
poloxamina y una o varias sustancias activas caracterizado por ser
una matriz biodegradable de consistencia sólida o semisólida con
aspecto homogéneo, un procedimiento de obtención basado en la fusión
de los componentes y composiciones farmacéuticas que comprenden
dicho sistema.
Patent AU-2001293229-B2 (AU)
Title: Thrombomodulin analogs for use in recovery of spinal cord injury
Inventor: FESTOFF BARRY W
IPC: A61K38/46
Filed: 2001-08-31
Granted: 2007-04-05
Abstract: The present invention relates to the use of thrombomodulin analogs for the treatment of trauma-induced spinal cord injury.
Patent AU-2002218013-B2 (AU)
Title: Belt installation tool
Inventor: AMKREUTZ FRANK
IPC: F16H7/24
Filed: 2001-10-31
Granted: 2005-03-10
Abstract: The invention comprises a belt installation tool (10) for installing a belt on a pulley. The tool (10) comprises a plurality of segments (11-17). The segments (11-17) and the headpiece (18) are connected by a flexible connector (30) with a headpiece (18) attached to one end of the string of segments (11-17). Each segment (11-17) comprises a belt bearing surface (21-27) and a lip (41-48) for engaging a pulley rim, thereby conforming to the curve of the pulley rim. The belt bearing surface (21-27) describes a tapered surface. A surface normal to the belt bearing surface on each segment (11-17) urges a belt from the tool onto a pulley as the pulley is turned.
Patent AU-2002300441-B2 (AU)
Title: UV-light-absorbing Quaternary Polysiloxanes
Inventor: LEIDREITER HOLGER
IPC: C11D3/37
Filed: 2002-08-07
Granted: 2006-10-19
Abstract: Ultraviolet absorbing quaternary polysiloxanes of specific formula, are new. The siloxanes contain quaternary nitrogen moieties which contain monovalent chromophore residues responsible for UV absorption. <??>UV absorbing quaternary polysiloxanes of formula (I) are new. <??>R<1> = 1-4C lower alkyl or phenyl; <??>R<2> = partially the same R<1>, with the remainder being of formula (Ia). The average molecule has ≥ 1 residue of formula (Ia); <??>a = 1-200; and <??>b = 0-10. <??>-M-Z<+>A<-> (Ia) <??>M = divalent ≥ 4C hydrocarbon with an OH group, interrupted by ≥ 1 oxygen atoms. The N-atom of the Z residue is bonded to the M residue via the C atom adjacent to the C-OH group in the M residue; <??>Z<+> = residue of formula (Ib); and <??>A<-> = (in)organic anion, originating from a conventional physiologically compatible acid (HA). <??>R<3>, R<4> = 1-22C alkyl or 2-22 alkenyl, optionally having alkyl or alkenyl OH groups; <??>R<5> = monovalent chromophore residue responsible for UV absorption, of formula (Ic); and <??>x = 0-6. <??>R<6> = a residue; <??>R<7> = -CH=CH-; <??>R<8> = H, alkyl, haloalkyl, halo, phenyl, OH, alkoxy, amino, alkylamino, dialkylamino, di(hydroxyalkyl)amino, or di(polyalkoxy)amino; <??>m, n = 0 or 1; and <??>o = 0-5. <??>An Independent claim is also included for the preparation of (I) by reacting a compound of formula (II) with an amine of formula (IIb). The compounds are reacted in a known way in amounts that each epoxide group has at least one corresponding amino group. The reaction is performed in the presence of a conventional physiologically compatible (in)organic acid (HA), at a temperature of 40-120 degrees C. <??>R<9> = partially the same R<1>, with the remainder comprising monovalent residue, corresponding in structure to M. R<9>, instead of bonding to Z and OH, has an epoxide group. The average molecule has ≥ 1 monovalent R<9> residue.
Patent AU-2002310238-B2 (AU)
Title: Adjuvant compositions and pesticides
Inventor: STRIDDE HOWARD M
IPC: C09K23/00
Filed: 2002-05-31
Granted: 2008-06-05
Abstract: The present invention provides agricultural surfactant adjuvants that enhance the bioefficacy of herbicides and other pesticides. Also provided are agriculturally-valuable compositions containing such surfactant adjuvants. One advantage to an adjuvant composition according to the invention is combined high efficacy and low toxicity, including low eye and skin irritancy and low aquatic toxicity. Sequesterant agents can also be added to condition calcium or other interfering ions or species present in spray water.
Patent AU-2002349946-B2 (AU)
Title: Scrub pad with printed rigid plates and associated methods
Inventor: KIM YOUNG LIN
IPC: A47L13/16
Filed: 2002-10-17
Granted: 2008-07-17
Abstract: The invention relates to a scrubbing material that combines at least two discrete components. One component is a continuous flexible substrate (106, 304, 706). A second component is a discontinuous abrasive layer affixed to the flexible substrate (106, 304, 706). The abrasive layer is a set of plates )108, 302, 402, 708) formed from a material different than the continuous flexible substrate (106, 304, 706). One or two flexible substrates (106, 304, 706) with affixed plates (108, 302, 402, 708) with an intermediate layer (702) such as sponge or terry cloth. The gaps (205, 301) between plates (108, 302, 402, 708) are relatively large and are generally larger than one-third the largest plate dimension (307). The flexible substrate (106, 304, 706) can be tightly woven fabric that can be printed with visually attractive colors, patterns and images. The plate material is a printable material 204 that subsequently solidifies, such as epoxy. The inventions include associated methods of use and manufacture.
Patent AU-2002361273-B2 (AU)
Title: Method of obtaining novel lutein-based formulations
Inventor: ORTIZ JUAN FRANCISCO LOPEZ
IPC: A23L33/155
Filed: 2002-12-20
Granted: 2008-06-12
Abstract: A method of obtaining new formulations based on lutein. <??>The present invention describes a method of preparation of formulations of microcrystalline lutein, particularly in the form of esters, which are resistant to oxidation and are soluble in hydrophilic and/or lipophilic media. For these formulations, the esters of lutein are mixed with antioxidants, vegetable oils and/or organic solvents, and this initial mixture is submitted to various stages depending on the type of final formulation required. These formulations are suitable for direct application as colourants in the pharmaceutical, food and cosmetics fields. They can also be used as diet supplements.
Patent AU-2003233320-B2 (AU)
Title: Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant
Inventor: JOHANSSON JAN
IPC: A61K38/00
Filed: 2003-05-12
Granted: 2008-06-19
Abstract: The invention relates to reconstituted surfactants consisting of artificial phospholipids and peptides able to lower the air-liquid surface tension, more particularly to reconstituted surfactants comprising special phospholipid mixtures and artificial peptides which are analogues of the natural surfactant SP-C protein for the treatment of respiratory distress syndrome (RDS) and other diseases relating to pulmonary surfactant dysfunctions.
Patent AU-2003261036-B2 (AU)
Title: Training apparatus
Inventor: PLANKE TORE
IPC: A63B29/02
Filed: 2003-08-27
Granted: 2009-01-08
Abstract: A training apparatus consisiting of a rope ( 2 ) which can be passed via a suspended direction reversal means ( 1 ), wherein a first part ( 2 ') of the rope is arranged to hang down from one side of the direction reversal means, wherein a handle loop ( 3 ) is provided at one end ( 2 '') of the first part ( 2 ') of the rope, and wherein a second part ( 2 ''') of the rope is arranged to hang down from another side of the direction reversal means and is designed to form releasable engagement with a locking device ( 4, 4 ') of the key way type, so-called "Cleatlock". The locking device ( 4 ) is secured to the first part of the rope, and the direction reversal means ( 1 ) is selected from the group consisting of: a beam, a bar, a guide tube, a guide channel, a pulley and a suspension bracket.
Patent AU-2003290898-B2 (AU)
Title: Organofunctional compounds for shale stabilization of the aqueous dispersed phase of non-aqueous based invert emulsion drilling system fluids
Inventor: GROVER PATRICK E
IPC: C09K8/34
Filed: 2003-11-13
Granted: 2011-07-21
Abstract: Invert emulsion drilling system fluids comprising an oleaginous continuous phase and a non-oleaginous dispersed phase, the dispersed phase comprising organofunctional compounds(s) effective to provide shale inhibition. The organofunctional compound(s) may be used either as a supplement to or as a substitute for metallic salts.
Patent AU-2004217969-B2 (AU)
Title: Thiolactones
Inventor: TSUKAMOTO TAKASHI
IPC: C07D498/02
Filed: 2004-03-03
Granted: 2011-03-03
Abstract: This invention provides new compounds, pharmaceutical compositions and diagnostic kits comprising such compounds, and methods of using such compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, inhibiting angiogenesis, effecting a TGF-² activity or a neuronal activity, and treating a glutamate abnormality, a compulsive disorder, neuropathy, pain, a prostate disease, cancer, Huntington's disease, diabetes, a retinal disorder or glaucoma.
Patent AU-2004231987-B2 (AU)
Title: Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
Inventor: WANG ZHE
IPC: A61P31/12
Filed: 2004-04-16
Granted: 2009-11-19
Abstract: The present invention relates to compounds of Formula (I) or (II), or a pharmaceutically acceptable salt, ester, or prodrug, thereof: formula (I), formula (II): which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Patent AU-2005248960-B2 (AU)
Title: Phenoxy carboxylic acid compounds and compositions for delivering active agents
Inventor: SMART JOHN E
IPC: C07C62/32
Filed: 2005-12-29
Granted: 2009-01-29
Abstract: Phenoxy carboxylic acid compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.
Patent AU-2005257064-B2 (AU)
Title: Chimeric proteins and uses thereof
Inventor: APPEL ELENA
IPC: C12N15/62
Filed: 2005-06-28
Granted: 2012-05-10
Abstract: The present invention provides a chimeric protein capable of killing or modifying a cell expressing abnormally high levels of a ligand of a receptor of the TNF/NGF family, comprising the amino acid sequence of at least one polypeptide consisting of an extracellular portion of said receptor connected to an effector molecule. In addition the invention provides pharmaceutical compositions comprising said chimeric protein and use thereof.
Patent AU-2006200685-B2 (AU)
Title: Pressure relief valve
Inventor: MCKENZIE ORTON REGINALD JAMES
IPC: A61M16/20
Filed: 2006-02-20
Granted: 2011-09-29
Abstract: A pressure relief valve is disclosed that may be used as both an over pressure control valve, preventing possible barotraumas to the patient; or as an overpressure control valve for a breathing circuit preventing over pressures caused by blockages in a breathing circuit (supplying 5 breathing gases to a patient) with the potential to damage either the humidifier or the breathing circuit. The pressure relief valve comprises a magnetic seating that is associated with an outlet vent formed on a breathing assistance apparatus, and a magnetic cover capable of covering the seating and the outlet vent. The cover is held against the seating by a magnetic force between the cover and the seating. The outlet vent is substantially sealed by the cover and when the pressure 10 of the gases in the breathing assistance apparatus exceeds a predetermined pressure value that overcomes the magnetic force, the cover releases from the seating to allow gases to exit the outlet vent and reduce the gases pressure in the breathing assistance apparatus Figure 2 I lK) Figure 3 // k Figure 4
Patent AU-2006252104-B2 (AU)
Title: Method for preparing polyolefins containing vinylidine end groups using nonaromatic heterocyclic compounds
Inventor: STOKES CASEY D
IPC: C08F8/00
Filed: 2006-12-18
Granted: 2013-01-17
Abstract: Disclosed is a method for preparing polyolefins containing vinylidine end groups from quasiliving carbocationically terminated polyolefin polymers by contacting the quasiliving carbocationically terminated polymer with a suitable nonaromatic heterocyclic ring quenching agent and substituted derivatives thereof
Patent AU-2006345511-B2 (AU)
Title: Methods for identifying sequence motifs, and applications thereof
Inventor: LEVINE ARNOLD
IPC: G16B20/30
Filed: 2006-11-30
Granted: 2013-03-21
Abstract: The present invention relates to methods and algorithms that can be used to identify sequence motifs that are either under- or over-represented in a given nucleotide sequence as compared to the frequency of those sequences that would be expected to occur by chance, or that are either under- or over-represented as compared to the frequency of those sequences that occur in other nucleotide sequences, and to methods of scoring sequences based on the occurrence of these sequence motifs. Such sequence motifs may be biologically significant, for example they may constitute transcription factor binding sites, mRNA stability/instability signals, epigenetic signals, and the like. The methods of the invention can also be used, inter alia, to classify sequences or organisms in terms of their phylogenetic relationships, or to identify the likely host of a pathogenic organism. The methods of the present invention can also be used to optimize expression of proteins.
Patent AU-2007211952-B2 (AU)
Title: Roll-over protective structure for a work vehicle with removable portion for air transport
Inventor: RAVI MODUKURI
IPC: B60R21/13
Filed: 2007-08-27
Granted: 2011-12-08
Abstract: ROLL-OVER PROTECTIVE STRUCTURE FOR A WORK VEHICLE WITH REMOVABLE PORTION FOR AIR TRANSPORT Abstract of the Disclosure A work vehicle includes a vehicle frame and a roll-over protective structure mounted to the frame. The roll-over protective structure includes a plurality of upright support posts supporting a roof. Each support post includes a lower post section and an upper post section detachably coupled together in an end-to-end arrangement. JDC0089.US/17529 |6 \\ 4 20
Patent AU-2007214284-B2 (AU)
Title: Seal with pyramid shaped formation
Inventor: MASKALIUNAS LINAS L
IPC: F16J15/34
Filed: 2007-08-28
Granted: 2012-08-02
Abstract: A seal assembly having a seal bumper wall with a series of pyramid shaped formations lying on the bumper wall. The formations cause their apex portion to wear down rapidly in use, while the remainder of the pyramids remain and act as 5 slingers and/or produce a convection effect to reduce temperature along the sealed area. In another embodiment, there are two each pyramid shaped formations located on each of several thrust bumpers. which are held in position by a retainer. 27AIX/(I7. ,7(4 .pecifiion. co
Patent AU-2007221497-B2 (AU)
Title: Porous layer
Inventor: PALM BJORN
IPC: C23C14/16
Filed: 2007-03-02
Granted: 2012-06-14
Abstract: Heat exchange device with a boiling surface comprising a porous surface layer arranged on a solid substrate, the porous surface layer comprises a porous wall structure defining and separating macro-pores that are interconnected in the general direction normal to the surface of the substrate and have a diameter greater than 5 μm and less than 1000 μm wherein the diameter of the pores gradually increases with distance from the substrate wherein the porous wall structure is a continuous branched structure.
Patent AU-2007239095-B2 (AU)
Title: Immunostimulatory combinations for vaccine adjuvants
Inventor: KORNBLUTH RICHARD SYD
IPC: A61K39/00
Filed: 2007-01-09
Granted: 2012-05-03
Abstract: This invention discloses immunostimulatory combinations of Tumor Necrosis Factor Receptor Superfamily (TNFRSF) agonists, Toll-Like Receptor (TLR) agonists, "domain present in IP,IITA, ET-E, P-I (NACHT)-eucine ich epeat (LRR)" or "NLR" agonists, RIG-I-Like Helicase or "RLH" agonists, purinergic receptor agonists and cytokine/chemokine receptor agonists, together with delivery methods. The combinations, when used alone at the site of pathology, provide immunostimulation that induces host humoral and cellular immunologic responses to eliminate pathogens or neoplasms. Alternatively, when the combinations are used with a defined antigens, these combinations can induce focused humoral and cellular immunologic responses useful as prophylactic and/or ameliorative therapeutic modalities for infections and the treatment of neoplastic disorders.
Patent AU-2007279331-B2 (AU)
Title: Dressing
Inventor: HARTWELL EDWARD YERBURY
IPC: A61F13/00
Filed: 2007-07-25
Granted: 2013-10-31
Abstract: A dressing (30), a grommet (10) and a combination thereof are described for making a dressing for use in locating and retaining conduits and/or tubes used in therapy of a wound is described, the dressing (30) comprising a backing layer (32) having an adhesive coating (34) thereon for adhering the dressing (30) to a patient; the backing layer (32) having a cut-out (48) therein for receiving a grommet member (10); said grommet member (10) having at least one aperture (14) therethrough for receiving a conduit; and, said grommet member (10) further comprising a flange portion (16) in some embodiments for attaching the grommet member (10) to said adhesive coated backing layer (32).
Patent AU-2007330410-B2 (AU)
Title: CPG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
Inventor: UHLMANN EUGEN
IPC: C07H21/00
Filed: 2007-09-27
Granted: 2012-07-26
Abstract: The invention relates to oligonucleotides including at least one lipophilic substituted nucleotide analog and a pyrimidine- purine dinucleotide. The invention also relates to pharmaceutical compositions and methods of use thereof.
Patent AU-2007341952-B2 (AU)
Title: Automatic vulnerability detection and response
Inventor: BRIDGE HENRY F
IPC: G06F15/00
Filed: 2007-12-31
Granted: 2011-10-13
Abstract: Various embodiments detect security vulnerabilities and, responsively, can modify an affected program so that even if an exploit runs, the program's integrity can be maintained. In at least some embodiments, a local automatic vulnerability detection and response (AVD/R) component executes on a user's local machine to detect and mitigate potential vulnerabilities through the use of a shield; and, a remote automatic vulnerability detection and response (AVD/R) component executes to report perceived vulnerabilities so that one or more shields can be delivered and applied locally to mitigate perceived vulnerabilities.
Patent AU-2007342333-B2 (AU)
Title: Alphavirus replicon particles encoding IL- 12 as immunological adjuvants
Inventor: ELLIS WHITNEY
IPC: A61K35/76
Filed: 2007-09-12
Granted: 2013-02-28
Abstract: The immune response to an antigen of interest, either in purified form or expressed via an alphavirus replicon particle, can be enhanced by the simultaneous administration of an alphavirus replicon particle which expresses interleukin-12. This allows for the use of significantly smaller quantities of the antigen and this immunization strategy can also eliminate the need for boosting administration of the antigen or it can reduce the number of boosts required for an effective immune response to the antigen.
Patent AU-2008202663-B2 (AU)
Title: Method and elevator drive with a brake device
Inventor: WEINBERGER KARL
IPC: B66B1/24
Filed: 2008-06-17
Granted: 2013-12-19
Abstract: Abstract 5 In this elevator drive with a brake device (1), compression springs (2, 3) act on brake levers, whereby brake linings (13, 16) generate a brake force on a brake drum (14). The more the brake linings (13, 16) wear due to abrasion, the smaller the distance (d) of the plunger (21) from the brake 10 magnet housing (19) becomes. Should the plunger (21) come into contact with the brake magnet housing, the braking capacity of the brake linings (13, 16) is completely eliminated. So that this operating condition that is dangerous for elevator users cannot occur, a switch (27) is 15 provided that detects a minimum distance (d). The switch (27) can be arranged on the plunger (21) of the brake magnet (4) and detect the minimum distance (d) to the brake magnet housing (19) or, in the case of a retrofit, the switch (27) can be arranged on the brake magnet rod (23) 20 and, for example, detect the distance of the second joint (24) from the brake magnet housing (19), and at the minimum distance (d) the switch (27) switches. 25 (Fig. 1) FIG. 1 27 23 4 d 11 -27 8- 8 1816 14 138 FIG. 2 d2 d1 27220.2 21.2 "L i19 2 3 .2 2 . 2 0 .21 . 18 - 13